We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,985 results
  1. Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats

    Liver cirrhosis can cause disturbances in blood circulation in the liver, resulting in impaired portal blood flow and ultimately increasing portal...

    **nyuan Wang, Juan Li, ... **abing Huang in Biochemical Genetics
    Article 04 March 2024
  2. Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency

    Timely detection of portal hypertension as a manifestation in a subgroup of patients with common variable immunodeficiency (CVID) represents a...

    Anna-Maria Globig, Valentina Strohmeier, ... Klaus Warnatz in Journal of Clinical Immunology
    Article Open access 11 July 2022
  3. A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension

    Objective

    Clinically significant portal hypertension (CSPH) seriously affects the feasibility and safety of surgical treatment for hepatocellular...

    Jia-zhou Ye, Hua-ze Lu, ... Le-qun Li in BMC Cancer
    Article Open access 25 June 2024
  4. Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice

    Background and aims

    Kinin B1 receptors (B1Rs) are implicated in the pathogenesis of fibrosis. This study examined the anti-fibrotic effects of B1R...

    Dileep Reddy Rampa, Huiying Feng, ... Dongmei Wu in Journal of Translational Medicine
    Article Open access 13 December 2022
  5. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study

    Background

    Portal hypertension (PHT) has been proven to be closely related to the development of hepatocellular carcinoma (HCC). Whether PHT before...

    Guo Wei, Yong Zhao, ... Jiayin Yang in BMC Cancer
    Article Open access 03 May 2024
  6. Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy

    Portal vein tumor thrombosis (PVTT), a common complication of advanced hepatocellular carcinoma (HCC), remains the bottleneck of the treatments....

    **ng-Hao Zhou, **g-Ru Li, ... Tong-Chun Xue in Clinical & Experimental Metastasis
    Article 01 November 2022
  7. Polygenic prediction of preeclampsia and gestational hypertension

    Preeclampsia and gestational hypertension are common pregnancy complications associated with adverse maternal and child outcomes. Current tools for...

    Michael C. Honigberg, Buu Truong, ... Pradeep Natarajan in Nature Medicine
    Article 29 May 2023
  8. Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study

    Background and objectives

    Patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombosis (PVTT) are presently lacking effective...

    **aoquan Ji, Zhe Xu, ... Quan Wang in Radiation Oncology
    Article Open access 12 June 2023
  9. Leopard-like retinopathy and severe early-onset portal hypertension expand the phenotype of KARS1-related syndrome: a case report

    Background

    Mutations in lysyl-tRNA synthetase ( KARS1 ), an enzyme that charges tRNA with the amino acid lysine in both the cytoplasm and mitochondria,...

    Francesca Peluso, Viviana Palazzo, ... Sabrina Giglio in BMC Medical Genomics
    Article Open access 21 January 2021
  10. Evidence for a relationship between genetic polymorphisms of the L-DOPA transporter LAT2/4F2hc and risk of hypertension in the context of chronic kidney disease

    Background

    Chronic kidney disease (CKD) and hypertension are chronic diseases affecting a large portion of the population frequently coexistent and...

    Paolina Crocco, Serena Dato, ... Giuseppina Rose in BMC Medical Genomics
    Article Open access 18 June 2024
  11. Gene-based association study reveals a distinct female genetic signal in primary hypertension

    Hypertension is a polygenic disease that affects over 1.2 billion adults aged 30–79 worldwide. It is a major risk factor for renal, cerebrovascular,...

    Roei Zucker, Michael Kovalerchik, Michal Linial in Human Genetics
    Article 03 May 2023
  12. Pulmonary Hypertension in Patients with Common Variable Immunodeficiency

    Purpose

    Common variable immunodeficiency (CVID) is known to cause infectious, inflammatory, and autoimmune manifestations. Pulmonary hypertension (PH)...

    Pierre Thoré, Xavier Jaïs, ... David Montani in Journal of Clinical Immunology
    Article 10 June 2021
  13. CD39 in the development and progression of pulmonary arterial hypertension

    Pulmonary arterial hypertension (PAH) is a devastating progressive disease characterised by pulmonary arterial vasoconstriction and vascular...

    Abbey Willcox, Natasha Ting Lee, ... Maithili Sashindranath in Purinergic Signalling
    Article Open access 10 August 2022
  14. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

    Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the remodeling of pulmonary blood vessels. If left unaddressed, PAH...

    Jaydev Dave, Vineeta Jagana, ... Malik Bisserier in Journal of Translational Medicine
    Article Open access 17 July 2023
  15. Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study

    Aims

    This study compared the prevalences of metabolic syndrome and of cardiac or kidney comorbidities among patients with hepatocellular carcinoma...

    Da-Long Yang, Shao-** Liu, ... Jian-Hong Zhong in Infectious Agents and Cancer
    Article Open access 01 May 2024
  16. Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate

    Transjugular intrahepatic portosystemic shunt (TIPS) has been used since more than 25 years to treat some of the complications of portal...

    Silvia Nardelli, Daniele Bellafante, ... Stefania Gioia in Metabolic Brain Disease
    Article 29 November 2022
  17. Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury

    Chronic liver injury can lead to hepatic failure and the only available method of treatment would be liver transplantation. The link between...

    Hasnaa A. Ebrahim, Samaa S. Kamar, ... Amal F. Dawood in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 22 June 2022
  18. Cell-to-Cell Crosstalk: A New Insight into Pulmonary Hypertension

    Pulmonary hypertension (PH) is a disease with high pulmonary arterial pressure, pulmonary vasoconstriction, pulmonary vascular remodeling, and...
    Chapter 2022
  19. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma

    Background

    There is currently no widely-accepted consensus for the management of hepatocellular carcinoma with portal vein tumor thrombus. We evaluate...

    Duo Hong, Yi Zhou, ... Haibo Shao in BMC Cancer
    Article Open access 14 September 2021
Did you find what you were looking for? Share feedback.